Skip to main content

Chemically Induced Hair Loss/Alopecia

  • Reference work entry
  • First Online:
  • 97 Accesses

Abstract

Increased shedding of hair and noticeable hair thinning or baldness (alopecia) are increasingly cited as side effects of exogenous chemicals/drugs.

This chapter reviews some drugs implicated as well as mechanisms that may be responsible, describes criteria for defining the mechanism, and proposes animal and human assay models. This background provides the basis of similar judgment as relates to percutaneous penetration (and inhalation) of chemicals at the work site.

Hair anatomy: Hair represents complete maturation of follicular matrical cells and is a fully cornified structure that emanates from a follicle and extends above the surface of the skin from varying distances. It has three components: an outer cuticle, a cortex, and an inner medulla. Hair grows in three phases: (1) growing or anagen, (2) involution or catagen, and (3) resting or telogen.

Nonchemical-related hair loss: Few endogenous events affecting hair growth are delineated. Extreme starvation or protein deprivation may result in formation of sparse or brittle hair through diminished mitotic activity. Also major systemic insult, such as high fever, major surgery, illness, or trauma may result in hair follicles being thrown into an untimely telogen effluvium.

Anagen versus telogen hair loss: Chemicals or medications may either cause excessive hair shedding by precipitating telogen development, directly poison the anagen root, or work in other undetermined ways. The phase of hair loss may be determined by examining the shed or easily plucked hair.

Proving that alopecia in an individual is caused by a chemical/drug may be difficult; the most conclusive demonstration of chemical-/drug-related hair loss is reproduction of hair loss with repeated administration of the putative materials. However, the pathobiology of the response of the human hair follicle to chemotherapy is largely unknown.

Hair loss is discussed in detail. Among the subjects of discussion are types of hair loss (e.g., anagen, medications precipitating telogen), chemicals causing hair loss (e.g., antimitotic agents, phenyl glycidyl ether), medications causing hair loss of unknown type (e.g., antithyroid drugs), medications possibly associated with hair loss, as well as chemically induced cosmetic alopecia, and typical scenarios in alleged occupational hair loss.

This is a preview of subscription content, log in via an institution.

Buying options

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   919.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD   1,299.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

References

  • Botchkarev VA (2003) Molecular mechanisms of chemotherapy-induced hair loss. J Invest Dermatol Symp Proc 8:72–75

    Article  CAS  Google Scholar 

  • Bronaugh R, Maibach HI (1991) Percutaneous absorption, 3rd edn. Marcel Dekker, New York

    Google Scholar 

  • Crounse RG, Van Scott EJ (1960) Changes in scalp hair roots as a measure of toxicity from cancer chemotherapeutic drugs. J Invest Dermatol 35:83–84

    Article  CAS  Google Scholar 

  • Falkson G, Schulz EJ (1964) Skin changes caused by cancer chemotherapy. Br J Dermatol 76:309–310

    Article  CAS  Google Scholar 

  • Goette DK, Odom RB (1975) Profuse hair loss. Arch Dermatol 111:930–932

    Article  CAS  Google Scholar 

  • Hubler WR (1966) Hair loss as a symptom of chronic thallotoxicosis. South Med J 59:436–442

    Article  CAS  Google Scholar 

  • Jackow C, Puffer N, Hordinsky M, Nelson J, Tarrand J, Duvic M (1998) Alopecia areata and cytomegalovirus infection in twins: genes versus environment? J Am Acad Dermatol 38:418–425

    Article  CAS  Google Scholar 

  • Kligman AM (1959) The human hair cycle. J Invest Dermatol 33:307

    Article  CAS  Google Scholar 

  • Kuìjpers AL, Van Baar HM, Van Gasselt MW, Van de Kerkhof PC (1995) The hair root pattern after calcipotriol treatment for scalp psoriasis. Acta Derm Venereol 75:388–390

    PubMed  Google Scholar 

  • Lee KP, Terrill JB, Henry NW (1977) Alopecia induced by inhalation exposure to phenyl glycidyl ether. J Toxicol Environ Health 3:85–87

    Article  Google Scholar 

  • Litt JZ, Shear N (2012) Litt’s drug eruptions & reactions manual, 18th edn. CRC Press, London

    Book  Google Scholar 

  • Maguire HC, Kligman AM (1964) Hair plucking as a diagnostic tool. J Invest Dermatol 43:77–78

    Article  Google Scholar 

  • Maibach HI (1974) In: Brown AC (ed) The first human hair symposium. Med Com Press, New York, p 399

    Google Scholar 

  • Maibach HI, Maguire HC (1964) Acute hair loss from drug-induced abortion. New Engl J Med 270:1112

    Article  CAS  Google Scholar 

  • Mehregan DA, Van Hale HM, Muller SA (1992) Lichen planopilaris: clinical and pathological study of 45 patients. J Am Acad Dermatol 27:935–942

    Article  CAS  Google Scholar 

  • Nicholson AG, Harland CC, Bull RH, Mortimer PS, Cook MG (1993) Chemically induced cosmetic alopecia. Br J Dermatol 128:537–541

    Article  CAS  Google Scholar 

  • Srivastava AK, Gupta BN, Bihari V, Gaur JS (1995) Generalized hair loss and selenium exposure. Vet Hum Toxicol 37:468–469

    CAS  PubMed  Google Scholar 

  • Stein KM, Odom RB, Justice GR, Martin GC (1973) Toxic alopecia from ingestion of boric acid. Arch Dermatol 108:95–97

    Article  CAS  Google Scholar 

  • Tosi A, Misciali C, Piraccini BM, Peluso AM, Bardazzi F (1994) Drug-induced hair loss and hair growth. Incidence, management and avoidance. Drug Saf 10:310–317

    Article  CAS  Google Scholar 

  • Van Dooren-Greebe RJ, Kuijpers AL, Mulder J, De Boo T, Van de Kerkhof PC (1994) Methotrexate revisited: effects of longterm treatment in psoriasis. Br J Dermatol 130:204–210

    Article  Google Scholar 

  • Wirth H, Dunsing W, Gloor M (1980) Telogen effluvium following application of selenium disulfide in the guinea pig. Hautarzt 31:502–504

    CAS  PubMed  Google Scholar 

  • Yang GQ, Wang SZ, Zhou RH, Sun SZ (1983) Endemic selenium intoxication of human in China. Am J Clin Nutr 37:872–881

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding authors

Correspondence to Becky S. Li or Howard I. Maibach .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2020 Springer Nature Switzerland AG

About this entry

Check for updates. Verify currency and authenticity via CrossMark

Cite this entry

Li, B.S., Maibach, H.I., Yamaguchi, I. (2020). Chemically Induced Hair Loss/Alopecia. In: John, S., Johansen, J., Rustemeyer, T., Elsner, P., Maibach, H. (eds) Kanerva’s Occupational Dermatology. Springer, Cham. https://doi.org/10.1007/978-3-319-68617-2_205

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-68617-2_205

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-68615-8

  • Online ISBN: 978-3-319-68617-2

  • eBook Packages: MedicineReference Module Medicine

Publish with us

Policies and ethics